Mmastodon ScienceScience first seen 13 h ago, last 13 h ago, peak #4
Steven Gygi opens day two of covalent drug discovery meeting
Original: The 2nd day of # CovModDrugDiscov gets on the way with an inspiring talk by Steven Gygi. He talked about the power of TM
The second day of the CovModDrugDiscov conference opened with an invited talk by Steven Gygi, a leading figure in proteomics. He presented how TMT multiplexing technologies enable high-throughput, residue-specific chemoproteomics, a method relevant to identifying targets of covalent inhibitor drugs. Attendees described the talk as inspiring, and the meeting continues to draw discussion across chemistry and chemical biology communities.
Why now: The covalent modifier drug discovery conference is currently underway and attendees are sharing highlights from its talks.
Evidence
- The 2nd day of # CovModDrugDiscov gets on the way with an inspiring talk by Steven Gygi. He talked about the power of TMT technologies for multiplexing to arrive at high-throughput residue-specific chemoproteomics. # CovalentInhibitor # DrugDiscovery # Chemistry # ChemBio #… · Stephanhacker2@mstdn.science · 2
API: https://socialmediatrends-api.osmike.com/v1/trends/1472081